Phase 3 trial of mRNA cancer vaccine + existing cancer drug reduced the risk of recurrence or death by 42% compared to the existing cancer drug alone.
The mRNA cancer vaccine Intismeran is made individually for each patient based on the the patient’s tumor and normal DNA in order to target tumor-specific antigens.
Moderna’s stocks tanked after the news event though the results were good, but I guess it wasn’t spectacular.
My neighbor was on Ketruda, and it almost killed him. He ended up having a stroke, and when he did some digging, he found out that his doctors should have stopped the Keytruda earlier when he had some bad side effects (they told him that they weren’t related). As much good as all of these breakthrough drugs can do, they can also have horrible side effects. It’s such a difficult thing to be faced with. Anything that can make taking the chance on such powerful drugs a better bet is a step forward.